Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4636901
Max Phase: Preclinical
Molecular Formula: C50H64N10O8S
Molecular Weight: 965.19
Molecule Type: Unknown
Associated Items:
ID: ALA4636901
Max Phase: Preclinical
Molecular Formula: C50H64N10O8S
Molecular Weight: 965.19
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCN(Cc1ccc(C(=O)NO)cc1)C(=O)Nc1ccc(OCCn2cc(CCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)nn2)cc1
Standard InChI: InChI=1S/C50H64N10O8S/c1-6-7-24-58(29-35-14-18-37(19-15-35)46(63)56-67)49(66)53-38-20-22-41(23-21-38)68-26-25-59-30-39(55-57-59)10-8-9-11-43(62)54-45(50(3,4)5)48(65)60-31-40(61)27-42(60)47(64)51-28-34-12-16-36(17-13-34)44-33(2)52-32-69-44/h12-23,30,32,40,42,45,61,67H,6-11,24-29,31H2,1-5H3,(H,51,64)(H,53,66)(H,54,62)(H,56,63)/t40-,42+,45-/m1/s1
Standard InChI Key: MFBAVOBTRVUMCR-BPHNBMEGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 965.19 | Molecular Weight (Monoisotopic): 964.4629 | AlogP: 6.26 | #Rotatable Bonds: 22 |
Polar Surface Area: 233.24 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 6 |
#RO5 Violations: 4 | HBA (Lipinski): 18 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 9.05 | CX Basic pKa: 2.65 | CX LogP: 4.65 | CX LogD: 4.64 |
Aromatic Rings: 5 | Heavy Atoms: 69 | QED Weighted: 0.03 | Np Likeness Score: -1.13 |
1. Yang K, Wu H, Zhang Z, Leisten ED, Nie X, Liu B, Wen Z, Zhang J, Cunningham MD, Tang W.. (2020) Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase., 11 (4): [PMID:32292566] [10.1021/acsmedchemlett.0c00046] |
Source(1):